Nissay Asset Management Corp Japan ADV Boosts Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Nissay Asset Management Corp Japan ADV grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% during the fourth quarter, Holdings Channel reports. The fund owned 24,054 shares of the medical device company’s stock after purchasing an additional 193 shares during the period. Nissay Asset Management Corp Japan ADV’s holdings in Cooper Companies were worth $2,221,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Byrne Asset Management LLC purchased a new position in shares of Cooper Companies during the 4th quarter worth approximately $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies during the 4th quarter worth approximately $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies in the 4th quarter worth approximately $38,000. Covestor Ltd grew its stake in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after buying an additional 120 shares during the last quarter. Finally, Atala Financial Inc purchased a new stake in shares of Cooper Companies in the 4th quarter worth approximately $51,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent research reports. JPMorgan Chase & Co. cut their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Citigroup cut their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Stock Performance

COO stock opened at $82.92 on Friday. The stock has a market capitalization of $16.58 billion, a PE ratio of 42.52, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $80.19 and its 200 day simple moving average is $90.10.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.